clinical-trial is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention CDC National Center for Injury Prevention and Control, the most common co-covered peer. Emergency Departments appears in 1 tracked Biotech story from August 7, 2026.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Emergency Departments
clinical-trial is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention CDC National Center for Injury Prevention and Control, the most common co-covered peer. Emergency Departments appears in 1 tracked Biotech story from August 7, 2026. The tracked stories average 2 original sources each.
Stories tracked
1
Sources per story
2
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 7 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Emergency Departments. Shared-story counts are live from our verified record — not editorial picks.
With 2.75 million suffering from cannabis hyperemesis syndrome and a 16% jump in ED diagnoses after a new ICD code, an underserved patient population emerges. Biopharma companies can explore targeted therapies for CHS, a condition currently managed only with abstinence and supportive care, presenting a significant unmet medical need.